Trials / Recruiting
RecruitingNCT07179744
Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer
A Multicenter, Prospective, Observational Study of Regional Radiotherapy Omission in Node Positive Patients With RecurIndex Low-risk Breast Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 635 (estimated)
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether certain patients can safely omit regional lymph node radiotherapy. These women must have hormone-sensitive, Her2-negative tumors, have 1-3 positive axillary nodes and have RecurIndex low-risk.
Conditions
Timeline
- Start date
- 2022-07-06
- Primary completion
- 2027-07-06
- Completion
- 2032-07-05
- First posted
- 2025-09-18
- Last updated
- 2025-09-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07179744. Inclusion in this directory is not an endorsement.